If The Pitt was truly honest, 80% of the show would just be exhausted residents in a 3 a.m. call room, eyes burning, staring at Epic while the coffee goes cold.
The trauma bays make for great TV. However, the real medical drama is the endless screen time, the pending admission notes, and the admins in the next room figuring out how to game the system.
Medical students don’t understand less. They know infinitely more in an era where facts are free and instant.
The real issue is an outdated curriculum still forcing rote memorization and exam theater instead of teaching judgment that shortens the path to a decision.
The students aren’t broken. The system is and it’s finally being forced to evolve.
The market is handing out $626M checks for obesity IPOs today, and it’s fascinating to watch.
But if you’ve spent any time managing clinical operations, you know a great molecule is just the starting line.
The real bottleneck isn’t the science anymore, it’s manufacturing scale and supply chain execution against giants like Eli Lilly and Novo.
We aren’t just funding biotech. We’re funding an industrial arms race.
Health AI is becoming the new safety valve.
14M Americans skipped a doctor visit this month after getting AI advice, trading wait-time friction for zero-friction access.
Meanwhile the Tempus/Medtronic ALERT trial shows embedded AI notifications are now the standard for closing care gaps in valvular heart disease.
This is how we scale real outcomes. #HealthTech #AI
The industry doesn't need more visionaries; it needs architects who can translate clinical friction into agentic plumbing.
The moat isn't the model; it's the workflow integration that ensures an AI agent is both safe and profitable.
@daniel_kraft@ChildrensPhila@PennMedicine 6 months to design a personalized CRISPR therapy correcting a single DNA misspelling in Baby KJ is remarkable.
This is how we finally scale real solutions for rare genetic diseases, one precise fix at a time.
@danshipper@every Biology and medicine are the next big thing in AI because it’s where intelligence finally meets messy, living systems and scales real human outcomes.
@sacjai We declare success prematurely, obscure failure, and skip rigorous longitudinal evidence.
The real innovation problem is rewarding narrative over durable outcomes.
Comparing yourself to others wastes time and stops real work. Success comes from finding unique insights and exploring places others ignore. Focus on your own path, not on copying competitors.
@themotleyfool Nothing is built to survive mistakes.
A diversified portfolio is built to adapt when they happen, and that adaptation is what actually compounds.
@RojaGarimella AI owns the continuous monitoring and routine adjustments.
One anesthesiologist in the control center owns the judgment and outcome for 10x cases.
That’s how care actually scales in the OR.
@OGdukeneurosurg The immune response to parasites often does more damage than the organism itself, especially when it crosses into the CNS.
Host inflammation is the real villain in these cases.
@TTrimoreau The internet didn't replace the expert; it killed the friction of finding the data.
AI follows the same evolutionary path. It automates the processing so we can finally scale the judgment.
The behind-the-scenes mess is the administrative tax we’ve accepted for too long.
Clinical AI is the force multiplier. It cleans the mess by scaling judgment and shortening the path to decisions.
The physician owns the outcome; the AI owns the friction. That is the infrastructure care needs to scale.